tetradecanoylphorbol acetate has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, HJ; De La Paz, MA; Hatchell, DL; Rao, KM | 1 |
| Ihm, SH; Park, CJ; Park, SW; Yoo, HJ | 1 |
1 trial(s) available for tetradecanoylphorbol acetate and Diabetic Retinopathy
| Article | Year |
|---|---|
Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Naphthalenes; Neutrophils; Reference Values; Regression Analysis; Respiratory Burst; Tetradecanoylphorbol Acetate | 1997 |
1 other study(ies) available for tetradecanoylphorbol acetate and Diabetic Retinopathy
| Article | Year |
|---|---|
Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; CD18 Antigens; Diabetic Retinopathy; Female; Humans; Integrins; L-Selectin; Macrophage-1 Antigen; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Tetradecanoylphorbol Acetate | 1997 |